We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

71 hedge funds and large institutions have $795M invested in Cullinan Oncology in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 22 increasing their positions, 19 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 19

1% more funds holding

Funds holding: 70 → 71 (+1)

6% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 17

1.55% less ownership

Funds ownership: 75.66% → 74.11% (-1.6%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

39% less capital invested

Capital invested by funds: $1.3B → $795M (-$504M)

Holders
71
Holders Change
+1
Holders Change %
+1.43%
% of All Funds
1.24%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
18
Increased
22
Reduced
19
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AIG
American International Group
New York
+$37.6M
2
DM
Deerfield Management
New York
+$32.1M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$23.3M
4
IC
Ikarian Capital
Texas
+$9.06M
5
Franklin Resources
Franklin Resources
California
+$8.89M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$30.2M
2
APM
Avidity Partners Management
Texas
-$29.5M
3
VC
Vivo Capital
California
-$10.4M
4
BI
BVF Inc
California
-$9.66M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$8.11M
Name Holding Trade Value Shares
Change 		Change in
Stake
MB
1
MPM BioImpact
Massachusetts
$204M – – –
FCMV
2
Foresite Capital Management V
California
$70.3M – – –
CA
3
CHI Advisors
New York
$57.8M +$1.24M +40,434 +2%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$50.9M +$23.3M +757,733 +62%
BG
5
Baupost Group
Massachusetts
$46.3M – – –
EAM
6
Eventide Asset Management
Massachusetts
$36.2M +$7M +227,590 +19%
Vanguard Group
7
Vanguard Group
Pennsylvania
$29.8M +$138K +4,478 +0.4%
O
8
OrbiMed
New York
$29.5M – – –
RSCM
9
Rock Springs Capital Management
Maryland
$27.7M – – –
BC
10
Boxer Capital
California
$27.7M – – –
DM
11
Deerfield Management
New York
$26.9M +$32.1M +1,044,000 New
VA
12
VR Adviser
New York
$25.1M -$6.15M -200,000 -17%
BlackRock
13
BlackRock
New York
$24.3M +$1.68M +54,470 +6%
Franklin Resources
14
Franklin Resources
California
$20M +$8.89M +289,190 +59%
BI
15
BVF Inc
California
$18.9M -$9.66M -314,250 -30%
WP
16
Woodline Partners
California
$14.5M +$563K +18,294 +3%
RCM
17
RA Capital Management
Massachusetts
$9.01M – – –
IC
18
Ikarian Capital
Texas
$7.61M +$9.06M +294,596 +29,460%
LGM
19
Logos Global Management
California
$7.43M -$3.84M -125,000 -30%
PVI
20
Pura Vida Investments
New York
$6.2M +$743K +24,168 +11%
Millennium Management
21
Millennium Management
New York
$6.02M -$5.23M -170,175 -42%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$6M +$389K +12,655 +6%
State Street
23
State Street
Massachusetts
$5.87M +$1.02M +33,028 +17%
EP
24
Eversept Partners
New York
$4.22M +$5.04M +163,880 New
Northern Trust
25
Northern Trust
Illinois
$3.41M -$273K -8,866 -6%
1
2 3 4

CGEM Hedge Fund Activity: Q2 2021 in Review

71 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q2 2021, worth a combined $795M — down 39% from $1.3B a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CGEM positions and 17 closed out — a net gain of 1 holder — while 22 added to existing stakes and 19 trimmed.

The largest buyer was American International Group, adding an estimated $37.6M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $30.2M sold.

  • 71 institutional investors held Cullinan Oncology (CGEM) as of Q2 2021, up from 70 in Q1 2021.
  • Funds reported $795M of Cullinan Oncology stock for Q2 2021, down 39% quarter-over-quarter.
  • 18 funds opened new Cullinan Oncology positions in Q2 2021 and 17 closed out, a net change of +1 holder.
  • The largest Cullinan Oncology buyer in Q2 2021 was American International Group, an estimated $37.6M added.
  • The largest Cullinan Oncology seller in Q2 2021 was T. Rowe Price Associates, an estimated $30.2M sold.

Based on aggregated 13F filings for Q2 2021.